MyBestMed®, Video |
Blog
Demonstrating the Value of Clinical Laboratory Medicine: Impact of Pharmacogenetic Panel Testing on a Health Plan
As healthcare costs continue to climb in the United States, drug costs are responsible for a disproportionate percentage of the overall healthcare spend. Pharmacogenetic testing has been scientifically validated as an option to help lower drug costs, yet little data exists on the testing’s potential to improve patient care while also lowering health plans’ costs. This presentation will provide the premise of pharmacogenetic testing then share how one self-insured company implemented pharmacogenetic screening of its high-risk populations as part of a collaborative laboratory/pharmacy stewardship program. Lessons learned and an examination of the financial and quality impacts of pharmacogentic panel testing will also be discussed.